BIOTECHNOLOGY VALUE FUND L P
Email Notification.
No 13F Holdings are in the database for the most recent quarter
Schedule 13D and 13G filings submitted since 09/30/2011
| Subject Company | Symbol | Date of Filing | Total Reported Shares Owned |
Shares Reported on 13F |
Change | |
|---|---|---|---|---|---|---|
| SC 13G/A | Palatin Technologies Inc. | PTN | 10/07/2011 | 5,200,000 | N/A | N/A |
| SC 13G/A | Neurocrine Biosciences Inc. | NBIX | 10/12/2011 | 5,895,965 | N/A | N/A |
| SC 13G | GenVec, Inc. | GNVC | 10/13/2011 | 796,100 | N/A | N/A |
| SC 13G | Affymax, Inc. | AFFY | 10/21/2011 | 2,156,100 | N/A | N/A |
| SC 13G | Myrexis, Inc. | MYRX | 10/28/2011 | 1,344,900 | N/A | N/A |
| SC 13G/A | Array BioPharma, Inc. | ARRY | 11/04/2011 | 8,026,116 | N/A | N/A |
| SC 13G/A | Ligand Pharmaceuticals Inc. | LGND | 11/23/2011 | 3,476,044 | N/A | N/A |
| SC 13G | Nektar Therapeutics | NKTR | 12/23/2011 | 7,415,400 | N/A | N/A |
| SC 13D/A | Kent International Holdings Inc. | KNTH.PK | 12/28/2011 | 0 | N/A | N/A |
| SC 13G/A | Flamel Technologies SA | FLML | 01/11/2012 | 1,972,251 | N/A | N/A |
| SC 13G/A | Neurocrine Biosciences Inc. | NBIX | 02/10/2012 | 5,928,865 | N/A | N/A |
| SC 13G/A | AP Pharma Inc. | APPA.OB | 02/10/2012 | 19,950,001 | N/A | N/A |
| SC 13G/A | Targacept, Inc. | TRGT | 02/10/2012 | 3,267,602 | N/A | N/A |
| SC 13G/A | GenVec, Inc. | GNVC | 02/10/2012 | 1,194,100 | N/A | N/A |
| SC 13G/A | Nektar Therapeutics | NKTR | 02/10/2012 | 7,639,000 | N/A | N/A |
| SC 13G/A | Rigel Pharmaceuticals, Inc. | RIGL | 02/10/2012 | 6,964,590 | N/A | N/A |
| SC 13G/A | Repligen Corporation | RGEN | 02/10/2012 | 0 | N/A | N/A |
| SC 13G/A | Astex Pharmaceuticals, Inc. | ASTX | 02/10/2012 | 0 | N/A | N/A |
| SC 13G/A | Infinity Pharmaceuticals, Inc. | INFI | 02/10/2012 | 2,184,908 | N/A | N/A |
| SC 13G/A | Array BioPharma, Inc. | ARRY | 02/10/2012 | 8,223,469 | N/A | N/A |